Posts
Displaying 1 - 13 of 13 results
Evidence Updates Share New Findings to Support Health Decision Making
Blog
PCORI’s mandate is to improve the quality and relevance of evidence that can help patients, caregivers, clinicians and others make better-informed health or healthcare decisions. Our Evidence Updates are one…
PCORI approves $123 million for research on postpartum care, hypertension management, antibiotic prescribing and a range of conditions
News Release
WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies. These studies aim to fill evidence gaps, enhance…
Annual Meeting Highlights Essential PCORI Values
Leadership Perspective
The eighth PCORI Annual Meeting last month highlighted so much of what makes our community special: a broad, diverse range of engaged stakeholders; inspirational expert speakers; compelling results from patient-centered…
PCORI Annual Meeting Keynote Speaker -- Co-Founder and President of Sick Cells -- Continues to Honor her Late Brother's Vision
Blog
Every day of the year, and not just during National Sickle Cell Awareness Month, Ashley Valentine, co-founder, and president of Sick Cells , celebrates the legacy of her late brother…
MEDIA ADVISORY: Health equity, COVID-19 research headline PCORI’s 2022 Annual Meeting October 26-27
News Release
WASHINGTON, D.C. — Registration is now open for the Patient-Centered Outcomes Research Institute (PCORI)’s 2022 Annual Meeting , a free, virtual event running October 26-27 that brings together patients and…
Spotlight on National Sickle Cell Disease Awareness Month
Blog
More than 100,000 people in the United States have sickle cell disease —a group of inherited red blood cell disorders that affect blood flow and the body’s use of oxygen…
PCORI Board of Governors approves $71.5 million to fund new research studies on topics including maternal health, autism, and urinary incontinence
News Release
WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research (CER)…
PCORI Researchers Are Answering Rapidly Emerging Questions about Telehealth
Blog
Telehealth—the use of digital information and communication technologies, such as computers and mobile devices, to access health care services remotely and manage health care—has grown in promise as technology has…
Can Some MS Patients Safely Stop Taking Medicines?
Blog
Multiple sclerosis is an often disabling neurological condition that affects about 400,000 people in the United States. People with MS can develop a wide variety of symptoms, including vision problems…
A Multifaceted Disease Requires a Patient-Centered Response
Blog
In 1986, I began experiencing bouts of numbness, fatigue, and lack of coordination on my left side. Those symptoms launched my 13-year journey toward a diagnosis of multiple sclerosis, or…
Can Patients with MS Safely Stop Taking Medicine as They Age? DISCOMS Trial's Results Indicate It's a Reasonable Option for Some
Research Study Highlight
Although new results from an ongoing PCORI-funded study into whether some patients with multiple sclerosis (MS) can safely stop taking certain kinds of medications as they age weren’t conclusive in…
TrACER Study: Changing Prescription Order Systems to Lower Risk of Febrile Neutropenia in Patients Starting Chemotherapy
Research Study Highlight
Some patients who receive chemotherapy develop a serious health problem called febrile neutropenia (FN), which involves having a fever and a low number of a type of white blood cells…
Emerging Health Care Innovation Brief: Treating Myotonic Dystrophy Type 1 and Expanded Use of Injectable Weight Loss Drugs
Highlight
The latest Emerging Health Care Innovation Brief looks at a few high-profile weight loss drugs that have received renewed attention with a recent policy decision that could expand their use…